ReportWire

Tag: fda

  • FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’

    [ad_1]

    The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal officials began reviewing “serious concerns about his personal conduct,” according to a government spokesperson.Dr. George Tidmarsh, who was named to the FDA post in July, was placed on leave Friday after officials in the Department of Health and Human Services’ Office of General Counsel were notified of the issues, HHS press secretary Emily Hilliard said in an email. Tidmarsh then resigned Sunday morning.“Secretary Kennedy expects the highest ethical standards from all individuals serving under his leadership and remains committed to full transparency,” Hilliard said.The departure came the same day that a drugmaker connected to one of Tidmarsh’s former business associates filed a lawsuit alleging that he made “false and defamatory statements,” during his time at the FDA.The lawsuit, brought by Aurinia Pharmaceuticals, alleges that Tidmarsh used his FDA position to pursue a “longstanding personal vendetta” against the chair of the company’s board of directors, Kevin Tang.Tang previously served as a board member of several drugmakers where Tidmarsh was an executive, including La Jolla Pharmaceutical, and was involved in his ouster from those leadership positions, according to the lawsuit.Messages placed to Tidmarsh and his lawyer were not immediately returned late Sunday.Tidmarsh founded and led a series of pharmaceutical companies over several decades working in California’s pharmaceutical and biotech industries. Before joining the FDA, he also served as an adjunct professor at Stanford University. He was recruited to join the agency over the summer after meeting with FDA Commissioner Marty Makary.Tidmarsh’s ouster is the latest in a string of haphazard leadership changes at the agency, which has been rocked for months by firings, departures and controversial decisions on vaccines, fluoride and other products.Dr. Vinay Prasad, who oversees FDA’s vaccine and biologics center, resigned in July after coming under fire from conservative activists close to President Donald Trump, only to rejoin the agency two weeks later at the behest of Health Secretary Robert F. Kennedy Jr.The FDA’s drug center, which Tidmarsh oversaw, has lost more than 1,000 staffers over the past year to layoffs or resignations, according to agency figures. The center is the largest division of the FDA and is responsible for the review, safety and quality control of prescription and over-the-counter medicines.In September, Tidmarsh drew public attention for a highly unusual post on LinkedIn stating that one of Aurinia Pharmaceutical’s products, a kidney drug, had “not been shown to provide a direct clinical benefit for patients.” It’s very unusual for an FDA regulator to single out individual companies and products in public comments online.According to the company’s lawsuit, Aurinia’s stock dropped 20% shortly after the post, wiping out more than $350 million in shareholder value.Tidmarsh later deleted the LinkedIn post and said he had posted it in his personal capacity, not as an FDA official.Aurinia’s lawsuit also alleges, among other things, that Tidmarsh used his post at FDA to target a type of thyroid drug made by another company, American Laboratories, where Tang also serves as board chair.The lawsuit, filed in U.S. District Court of Maryland, seeks compensatory and punitive damages and “to set the record straight,” according to the company.

    The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal officials began reviewing “serious concerns about his personal conduct,” according to a government spokesperson.

    Dr. George Tidmarsh, who was named to the FDA post in July, was placed on leave Friday after officials in the Department of Health and Human Services’ Office of General Counsel were notified of the issues, HHS press secretary Emily Hilliard said in an email. Tidmarsh then resigned Sunday morning.

    “Secretary Kennedy expects the highest ethical standards from all individuals serving under his leadership and remains committed to full transparency,” Hilliard said.

    The departure came the same day that a drugmaker connected to one of Tidmarsh’s former business associates filed a lawsuit alleging that he made “false and defamatory statements,” during his time at the FDA.

    The lawsuit, brought by Aurinia Pharmaceuticals, alleges that Tidmarsh used his FDA position to pursue a “longstanding personal vendetta” against the chair of the company’s board of directors, Kevin Tang.

    Tang previously served as a board member of several drugmakers where Tidmarsh was an executive, including La Jolla Pharmaceutical, and was involved in his ouster from those leadership positions, according to the lawsuit.

    Messages placed to Tidmarsh and his lawyer were not immediately returned late Sunday.

    Tidmarsh founded and led a series of pharmaceutical companies over several decades working in California’s pharmaceutical and biotech industries. Before joining the FDA, he also served as an adjunct professor at Stanford University. He was recruited to join the agency over the summer after meeting with FDA Commissioner Marty Makary.

    Tidmarsh’s ouster is the latest in a string of haphazard leadership changes at the agency, which has been rocked for months by firings, departures and controversial decisions on vaccines, fluoride and other products.

    Dr. Vinay Prasad, who oversees FDA’s vaccine and biologics center, resigned in July after coming under fire from conservative activists close to President Donald Trump, only to rejoin the agency two weeks later at the behest of Health Secretary Robert F. Kennedy Jr.

    The FDA’s drug center, which Tidmarsh oversaw, has lost more than 1,000 staffers over the past year to layoffs or resignations, according to agency figures. The center is the largest division of the FDA and is responsible for the review, safety and quality control of prescription and over-the-counter medicines.

    In September, Tidmarsh drew public attention for a highly unusual post on LinkedIn stating that one of Aurinia Pharmaceutical’s products, a kidney drug, had “not been shown to provide a direct clinical benefit for patients.” It’s very unusual for an FDA regulator to single out individual companies and products in public comments online.

    According to the company’s lawsuit, Aurinia’s stock dropped 20% shortly after the post, wiping out more than $350 million in shareholder value.

    Tidmarsh later deleted the LinkedIn post and said he had posted it in his personal capacity, not as an FDA official.

    Aurinia’s lawsuit also alleges, among other things, that Tidmarsh used his post at FDA to target a type of thyroid drug made by another company, American Laboratories, where Tang also serves as board chair.

    The lawsuit, filed in U.S. District Court of Maryland, seeks compensatory and punitive damages and “to set the record straight,” according to the company.

    [ad_2]

    Source link

  • FDA’s top drug regulator quits as agency officials probe actions

    [ad_1]

    Washington — The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal officials began reviewing “serious concerns about his personal conduct,” according to a government spokesperson.

    Dr. George Tidmarsh, who was named to the FDA post in July, was placed on leave Friday after officials in the Department of Health and Human Services’ Office of General Counsel were notified of the issues, HHS press secretary Emily Hilliard said in an email. Tidmarsh then resigned Sunday morning.

    “Secretary Kennedy expects the highest ethical standards from all individuals serving under his leadership and remains committed to full transparency,” Hilliard said.

    The departure came the same day that a drugmaker connected to one of Tidmarsh’s former business associates filed a lawsuit alleging that he made “false and defamatory statements” during his time at the FDA.

    The lawsuit, brought by Aurinia Pharmaceuticals, alleges that Tidmarsh used his FDA position to pursue a “longstanding personal vendetta” against the chair of the company’s board of directors, Kevin Tang.

    Tang previously served as a board member of several drugmakers where Tidmarsh was an executive, including La Jolla Pharmaceutical, and Tidmarsh was involved in his ouster from those leadership positions, according to the lawsuit.

    Messages placed to Tidmarsh and his lawyer were not immediately returned late Sunday.

    Tidmarsh founded and led a series of pharmaceutical companies over several decades working in California’s pharmaceutical and biotech industries. Before joining the FDA, he also served as an adjunct professor at Stanford University. He was recruited to join the agency over the summer after meeting with FDA Commissioner Marty Makary.

    Upheaval at FDA  

    Tidmarsh’s ouster is the latest in a string of leadership changes at the agency, which has been rocked for months by firings, departures and controversial decisions on vaccines, fluoride and other products.

    Dr. Vinay Prasad, who oversees FDA’s vaccine and biologics center, resigned in July after coming under fire from conservative activists close to President Trump, only to rejoin the agency two weeks later at the behest of Health Secretary Robert F. Kennedy Jr.

    The FDA’s drug center, which Tidmarsh oversaw, has lost more than 1,000 staffers over the past year to layoffs or resignations, according to agency figures. The center is the largest division of the FDA and is responsible for the review, safety and quality control of prescription and over-the-counter medicines.

    In September, Tidmarsh drew public attention for a highly unusual post on LinkedIn stating that one of Aurinia Pharmaceutical’s products, a kidney drug, had “not been shown to provide a direct clinical benefit for patients.” It’s very unusual for an FDA regulator to single out individual companies and products in public comments online.

    According to the company’s lawsuit, Aurinia’s stock dropped 20% shortly after the post, wiping out more than $350 million in shareholder value.

    Tidmarsh later deleted the LinkedIn post and said he had posted it in his personal capacity, not as an FDA official.

    Aurinia’s lawsuit also alleges, among other things, that Tidmarsh used his post at FDA to target a type of thyroid drug made by another company, American Laboratories, where Tang also serves as board chair.

    The lawsuit, filed in U.S. District Court of Maryland, seeks compensatory and punitive damages and “to set the record straight,” according to the company.

    [ad_2]

    Source link

  • Kennedy Announces New Cost-Saving Drug Plan – KXL

    [ad_1]

    WASHINGTON, DC – The White House is announcing another plan meant to lower the cost of prescription drugs in the U.S.  On Wednesday, Health and Human Services Secretary Robert F. Kennedy, Jr. announced said the Food and Drug Administration will be making it easier for ” biosimilars” to enter U.S. markets, something Europe has been doing for decades. Biosimilars are drugs similar to those that have been proven to work and have already been approved by the FDA.

    “This is a victory for patients, for innovation, and commonsense,” Kennedy told reporters. “In Europe, for example, regulators have approved more than twice as many biosimilars as the United States,” he added.

    Kennedy says he is cutting the red tape, and clinical trials that are necessary before these types of drugs can be sold in the U.S.

     

    More about:

    [ad_2]

    Tim Lantz

    Source link

  • A consumer’s guide to products claiming FDA approval

    [ad_1]

    An Instagram ad catches your eye. You click to the product’s website and find reassurance: The product, it says, is “FDA certified” or was “produced in an FDA registered facility.”

    Mention of the U.S. Food and Drug Administration — the agency that regulates drugs, biological products, medical devices, food and cosmetics — might give it the veneer of legitimacy. But not all claims about FDA approval, certification or registration are created equal. 

    The FDA warns that some companies advertise products using fake FDA registration certificates. 

    It can be hard to navigate. 

    “Consumers should be aware that many terms and claims may be misleading and have little, if any, relevance regarding the safety or effectiveness of the product,” said Aaron Lottes, a Purdue University engineering professor with medical device regulation expertise.

    Here’s a consumer guide to the FDA’s regulatory terms — and other terms you might encounter that don’t really come from the agency at all. 

    ‘FDA approved’

    It means: The FDA determined the product is safe and effective for its intended use. For drugs, it means the drug’s benefits outweigh its known and potential risks when used for its intended purpose and following its approved labeling.

    The FDA evaluates lab, animal and clinical testing outcomes and other scientific information to assess whether a product is safe and effective and whether it can be made according to federal quality standards. 

    Things the FDA approves include: 

    • Drugs or products meant to treat or prevent disease.

    • Biological products such as gene therapies, therapeutic proteins, vaccines, allergenic products and products made from plasma.

    • High-risk human medical devices, including mechanical heart valves and implantable infusion pumps.

    • Human food additives that are added to food for a specific purpose, such as when xanthan gum is added to a food to add texture. 

    • Color additives used in food, dietary supplements, drugs, cosmetics and some medical devices.

    The FDA generally does not approve cosmetics such as moisturizers, perfumes, makeup, shampoos, toothpastes and deodorants; infant formula; dietary supplements; food labels or nutrition facts; facilities such as doctors’ offices or labs; or tobacco products. It also does not approve compounded drugs, which a pharmacist or doctor might create to meet the needs of patients with allergies. Another example would include the creation of a compounded liquid formulation of a medication commonly available as a pill for someone with a condition that makes swallowing difficult. 

    Some things fall in between. A product might be both a cosmetic and a drug if it has more than one use and one of its uses would contribute to a disease’s diagnosis, cure, mitigation, treatment or prevention. 

    “An antidandruff shampoo is a cosmetic because its intended use is to cleanse the hair, and it is also a drug because its intended use is to treat dandruff,” the FDA said in a statement. 

    Another example would be antiperspirant deodorant or makeup containing sun protection, the statement said. 

    How to verify a company’s claims about FDA approval: Search the FDA’s approved drug database, the cleared and approved medical devices database and the approved animal drugs database

    ‘FDA certified’

    It means: The only type of official FDA certification we found applies to a mammography facility that meets strict standards for providing quality mammograms, X-ray pictures of breasts to help with earlier breast cancer detection. 

    Federal law requires mammography facilities be certified as capable of providing quality mammograms by either the FDA or FDA-approved certification agencies in Illinois, Iowa, South Carolina or Texas. A facility must stop providing mammograms if it is not certified.

    The FDA generally does not certify medical devices or facilities that make them.

    Renee Jeria, the imaging manager, shows the working of the mammography screening machine at the Samuel U. Rodgers Health Center on April 25, 2023 in Kansas City, Mo. (AP)

    How to verify if your mammogram facility is certified: Search the FDA’s certified mammography facilities list or, when you’re there, look for a displayed FDA certificate.

    Watch out for: Companies using fake certificates to claim a product or medical device is FDA certified — a practice the FDA said increased during the COVID-19 pandemic. These fake certificates often mimic official government documents and display the FDA logo.

    ‘FDA registered’

    It means: The FDA has registration paperwork on file from the owners of a domestic or foreign food, drug or medical device facility that produces and distributes products sold in the U.S.

    A facility’s registration with the FDA does not mean the agency approved, cleared or authorized it or the products it creates or distributes. The FDA doesn’t approve facilities, but it can inspect them to verify that they comply with relevant good manufacturing practices and other requirements.

    A facility must be registered if it: 

    How to verify if something is FDA-registered: Search the FDA’s database of registered medical device manufacturers and the registered tobacco product facilities.

    PolitiFact Staff Researcher Caryn Baird contributed to this report.

    [ad_2]

    Source link

  • Oregon E. coli Case Linked To Washington Cheese – KXL

    [ad_1]

    PORTLAND, OR – The Oregon Health Authority reports that an Oregon resident is one of three people who tested positive for E. Coli bacteria after eating unpasteurized aged cheese produced at the Twin Sisters Creamery Farmhouse in Washington state.

    Samples of leftover cheese obtained from the Oregon resident were tested at a laboratory, and those tests confirmed the presence of  the same E. coli pathogen that was found in two Washington state residents who had indirect exposure to cheese from the same company.  All three people experienced symptoms of E.coli infection between September 5th and September 16th. 

    Twin Sisters Peppercorn Cheese. Courtesy FDA.
    Twin Sisters Farmhouse Cheese. Courtesy FDA.
    Twin Sisters Mustard Seed Cheese. Courtesy FDA.
    Twin Sisters Whatcom Blue Cheese. Courtesy FDA.

    All sizes of Whatcom Blue, Farmhouse, Peppercorn and Mustard Seed varieties of aged cheese from Twin Sisters Creamery produced on or after May 27, 2025, are being recalled.

    • #450 Made on 5/27/2025 – Batch Code 250527B Whatcom Blue
    • #452 Made on 6/10/2025 – Batch Code 250610B Whatcom Blue
    • #454 Made on 6/18/2025 – Batch Code 250618B Whatcom Blue
    • #455 Made on 6/24/2025 – Batch Code 250625B Whatcom Blue
    • #451 Made on 6/03/2025 – Batch Code 250603F Farmhouse
    • #453 Made on 6/16/2025 – Batch Code 250616B Farmhouse
    • #451 Made on 6/03/2025 – Batch Code 250603P Peppercorn
    • #453 Made on 6/16/2025 – Batch Code 250616 Mustard Seed

    Some cheese products were repackaged by grocery stores and markets, so the original label may not be present. In these instances, the grocery store label should say the brand of cheese.

    For additional information about the investigation of these E. coli infections, read the Washington State Department of Health’s announcement.

    More about:

    [ad_2]

    Tim Lantz

    Source link

  • FDA unveils drugs to receive expedited review in support of ‘national priorities’

    [ad_1]

    By MATTHEW PERRONE

    WASHINGTON (AP) — The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically expedited reviews at the agency, part of an effort to prioritize medicines the Trump administration deems as “supporting U.S. national interests.”

    [ad_2]

    The Associated Press

    Source link

  • Beloved Partner Of Marijuana Faces Recall

    [ad_1]

    Cinnamon’s recall hits cannabis fans hard — the beloved spice enhances marijuana mornings, nights, and everything between

    Cinnamon toast is one of life’s simple pleasures — warm, sweet, and nostalgic. As a good the combination of warm toast, sugar, butter and cinnamon brought smiles on a school morning. But for many cannabis enthusiasts, it has become more than a breakfast comfort; it’s a favorite flavor pairing enhancing both body and mind. So when news hit several this beloved partner of marijuana faces recall, fans of this perfect cannabis companion let out a collective groan: ARGH!

    RELATED: Cannabis Can Help PTSD

    The spice rack staple, prized for its sweet heat and cozy aroma, has long been used alongside marijuana for both culinary and wellness reasons. Whether sprinkled into a morning edible or infused in a nighttime tea, cinnamon doesn’t just taste good — it enhances how people experience cannabis.

    Cinnamon Toast

    Here’s why: cinnamon’s natural compounds, particularly cinnamaldehyde, are known to support metabolism and blood sugar balance, while its scent helps trigger a calm, focused state. When paired with cannabis strains contain mood-lifting terpenes like limonene or pinene, the result can be an energizing and joyful start to the day. Cinnamon-infused cannabis coffees or low-dose edibles are especially popular among millennials looking for a more natural “wake and bake” which doesn’t leave them groggy.

    At night, the combo flips. A cinnamon-chamomile tea blended with a relaxing cannabis strain rich in myrcene or linalool can help calm racing thoughts, ease muscle tension, and support better sleep. It’s a cozy ritual feeling more like self-care than indulgence — a perfect wind-down for the overstimulated generation.

    RELATED: Is Cannabis Now The #1 Sleep Aid

    But with the current recall affecting certain batches of ground cinnamon, many cannabis-friendly kitchens are pressing pause. The recall, linked to potential contamination concerns, is a reminder not all natural products are created equal. Experts recommend checking product labels and buying organic or certified-safe cinnamon when using it in cannabis recipes, tinctures, or infusions.

    While cinnamon might be off the menu temporarily, fans aren’t giving up on this spicy soulmate. After all, few things beat the comfort of a cinnamon-dusted edible or the aroma of cannabis and cinnamon wafting together through a kitchen on a lazy Sunday morning.

    [ad_2]

    Amy Hansen

    Source link

  • FDA Adds Label Warning to J&J’s and Legend Biotech’s Cancer Therapy

    [ad_1]

    The U.S. Food and Drug Administration approved on Friday labeling changes for the blood cancer therapy of Johnson & Johnson and its partner Legend Biotech to include a warning for a potentially fatal gastrointestinal condition.

    Such a warning appears on the medicine’s label and is the most serious issued by the FDA.

    The FDA said it received reports that some patients treated with Carvykti developed a serious gut inflammation called IEC-EC, which in some cases led to life-threatening complications like bowel perforation and sepsis.

    Reports were received from clinical trials and postmarketing adverse event data, the FDA said.

    IEC-EC is a form of inflammation of the intestines triggered by the immune system. It was observed weeks to months after CAR-T therapy treatment with Carvykti in both clinical trials and after approval, the regulator said.

    Symptoms included persistent diarrhea, stomach pain and weight loss, often requiring intensive care and immune-suppressing drugs.

    A spokesperson for Johnson & Johnson said: “With more than 8,500 patients treated, the overall benefit/risk for Carvykti continues to be favorable, demonstrating durable responses with statistically significant progression-free survival and overall survival benefits.

    “The Carvykti label was also updated to include data showing a superior overall survival benefit versus standard therapies… at nearly three years of follow-up in patients receiving one to three prior lines of therapy.”

    Carvykti was first approved in February 2022 and received expanded approval in April 2024 for adults with relapsed or refractory multiple myeloma who had received at least one prior line of therapy.

    Multiple myeloma is an incurable blood cancer that affects a type of white blood cell called plasma cells, found in the bone marrow.

    The FDA also updated the “clinical studies” section of the drug’s prescribing information to include overall survival data from the late-stage trial.

    The interim data of the late-stage study showed a statistically significant improvement in survival for patients receiving Carvykti compared to those on standard therapy, with a median follow-up of 33.6 months.

    Despite the new safety concerns, the FDA said the overall benefit of Carvykti continues to outweigh the risks for its approved use.

    Reporting by Siddhi Mahatole in Bengaluru; Editing by Alan Barona and Muralikumar Anantharaman

    [ad_2]

    Reuters

    Source link

  • Pasta salad recall map shows new warning in 24 states

    [ad_1]

    Sprouts Farmers Market of Phoenix, Arizona, is recalling select lots of their Smoked Mozzarella Pasta Salad due to fears the product could be contaminated with Listeria monocytogenes.

    Newsweek reached out to the company via email on Thursday for comment.

    Why It Matters

    Numerous public health alerts and recalls have been initiated this year because of the potential for damaged products, foodborne illness, contamination and undeclared food allergens.

    Millions of Americans experience food sensitivities or allergies every year. According to the Food and Drug Administration (FDA), the nine “major” food allergens in the United States are eggs, milk, fish, wheat, soybeans, crustacean shellfish, sesame, tree nuts and peanuts.

    “Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women,” the alert warns in part.

    What To Know

    The alert notes that the recalled product was sold at the deli service bar and via the grab-and-go section of the store.
    The recalled product was distributed to Sprouts’ stores in Alabama, Arizona, California, Colorado, Delaware, Florida, Georgia, Kansas, Louisiana, Maryland, Missouri, North Carolina, New Jersey, New Mexico, Nevada, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington and Wyoming.

    The impacted pasta salad was sold in plastic containers or packaged directly from the deli counter, the alert notes.

    The UPC code for the recalled product sold from the grab-and-go sections is 2-15786-00000 with use-by dates ranging from October 10, 2025, to October 29, 2025. The UPC code for the recalled product sold via “Service Case” is 2-15587-00000 with use-by dates also ranging from October 10, 2025, to October 29, 2025.

    Below is a map showing the states impacted by the recall:

    What People Are Saying

    The alert in part: “This follows a recall initiated by Fresh Creative Foods, due to possible Listeria monocytogenes contamination of the pasta ingredient that was manufactured by Nate’s Fine Foods of Roseville, CA. This recall is being made with the knowledge of the U.S. Food and Drug Administration.”

    What Happens Next

    People who have purchased the recalled pasta salad are urged to dispose of the product or return it to the original place of purchase for a refund, the alert says.

    Customers with additional questions may contact the company via phone at 480-814-8016 on weekdays from 9 a.m. to 4 p.m. MT or by contact form.

    [ad_2]

    Source link

  • Nearly 4 Million Pounds of Chicken Corn Dogs Recalled Over Wood

    [ad_1]

    Foster Poultry Farms is recalling more than 3.8 million pounds of chicken corn dog products after wood was found in the batter, resulting in injuries.

    The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced the massive recall on Saturday, affecting approximately 3,843,040 pounds of products that may be contaminated with pieces of wood embedded in the batter. The Livingston, California-based establishment received numerous consumer complaints, with at least five reported injuries from consumption of the affected products.

    Newsweek reached out to Foster Poultry Farms via online submission form on Sunday for comment.

    Why It Matters

    This latest recall represents the second major corn dog contamination incident in just one week, signaling potential systemic safety failures within the processed meat industry.

    On September 28 the Hillshire Brands Company issued an even larger recall of approximately 58 million pounds of corn dog and sausage on a stick product, also due to wood contamination that injured five consumers

    The contamination involves pieces of wood embedded in the batter of corn dogs, creating a serious injury risk for anyone consuming these products. With distribution reaching schools and military facilities nationwide, the recall highlights the potential for widespread health impacts when safety protocols fail in large-scale food production.

    What To Know

    The Foster Farms recalled chicken corn dog products were manufactured between July 30, 2024, and August 4, 2025, and were sold under various brand names, including “Chicken Corn Dogs Batter Wrapped Chicken Frankfurters on a Stick” and “Corn Dogs Chicken Franks Dipped in Honey Batter.”

    Consumers can identify affected products by looking for the establishment number “P-6137B” printed either inside the USDA mark of inspection or on the packaging.

    The products were distributed to retail and institutional locations across the United States, including Department of Defense facilities and through USDA Commodity Foods donations. While some products reached schools through commercial sales, FSIS clarified they were not part of food provided by the USDA for the National School Lunch Program.

    The contamination was discovered after FSIS received a consumer complaint involving an injury, prompting further investigation that revealed multiple additional complaints to the company. The establishment received numerous consumer complaints, with five specifically involving injuries from wood pieces found in the products.

    FSIS has classified this as a serious health risk, with officials expressing particular concern that affected products may still be stored in consumers’ refrigerators and freezers, as well as in institutional storage facilities.

    The agency emphasized that these products should not be consumed under any circumstances and should be immediately discarded or returned to the place of purchase for a refund.

    A full list of the products subject to recall can be found here.

    What Should Consumers Do?

    Consumers who have experienced injuries or health issues related to these products are advised to seek immediate medical attention and report their experiences through the Electronic Consumer Complaint Monitoring System at https://foodcomplaint.fsis.usda.gov/eCCF/, available 24 hours a day.

    The USDA Meat and Poultry Hotline (888-674-6854) remains available for food safety questions and concerns.

    What Happens Next?

    FSIS will conduct comprehensive recall effectiveness checks to verify that Foster Farms properly notifies all customers and takes necessary steps to ensure the contaminated products are completely removed from commerce.

    The agency will post retail distribution lists on its website at www.fsis.usda.gov/recalls as they become available, allowing consumers to check if their local stores received the affected products.

    Reporting from the Associated Press contributed to this article.

    [ad_2]

    Source link

  • Pet treat recall prompts new warning to customers 

    [ad_1]

    Best Buy Bones, Inc., is recalling four lots of Nature’s Own brand of Pet Chews Bully Bites pet treats in 1-pound packages, due to fears the product could be contaminated with salmonella.

    Why It Matters

    Numerous public health alerts and recalls have been initiated this year because of the potential for damaged products, foodborne illness, contamination and undeclared food allergens.

    Millions of Americans experience food sensitivities or allergies every year. According to the Food and Drug Administration (FDA), the nine “major” food allergens in the United States are eggs, milk, fish, wheat, soybeans, crustacean shellfish, sesame, tree nuts and peanuts.

    “Salmonella can affect animals eating the products and there is risk to humans from handling contaminated pet products, especially if they have not thoroughly washed their hands after having contact with the products or any surfaces exposed to these products,” the alert warns in part.

    What To Know

    The alert says that 34 bags of the recalled product were distributed in Minnesota and then sold in stores in Wisconsin after September 23, 2025.

    The Nature’s Own Pet Chews Bully Bites have a UPC number of 739598900750 and packaged in 16-ounce bags with a resealable plastic pouch, the alert says.

    There have been no reported illnesses in dogs related to the recall as of Friday, the alert notes.

    The recalled product has a best-by date of September 2027, and the impacted lot numbers are 19379, 19380, 19381 and 19382.

    What People Are Saying

    The alert in part: “The health risk was discovered when samples of the product were collected on September 11, 2025, and tested by the Food and Drug Administration. The product tested positive for Salmonella. The company has ceased production and distribution of this product as the FDA, and the company continue their investigation into what caused the problem.”

    Arnold Mcintyre, chief operating officer of Best Buy Bones, Inc., to Newsweek via phone on Friday: “We have identified locations of all 34 bags and are now waiting on confirmation they have been destroyed.”

    What Happens Next

    People who have purchased the product are advised to dispose of it in a manner that children, wildlife and pets cannot access it, or return it to the original place of purchase, the alert says.

    “Do not sell or donate the recalled products. Do not feed the recalled product to pets or any other animals. Wash and sanitize pet food bowls, cups, and storage containers,” the alert notes.

    Customers with additional questions may contact the company via phone at 810-687-2106 from 8 a.m. to 5 p.m. ET Monday to Thursday.

    [ad_2]

    Source link

  • Republican fury after FDA approves abortion pill: ‘Complete betrayal’

    [ad_1]

    Several Republican figures have spoken out against the Donald Trump administration’s approval of an abortion pill, with former Vice President Mike Pence calling it a “complete betrayal of the pro-life movement.”

    The Food and Drug Administration (FDA) gave the green light to a new generic version of mifepristone on Tuesday, Drugmaker Evita Solutions announced on its website.

    Pence is one of multiple conservatives who have criticized the move—he called on Trump to reverse the decision.

    Newsweek has contacted the FDA and Evita Solutions, via email, for comment.

    Why It Matters

    The decision has ignited intense backlash from Republican lawmakers and anti-abortion groups, highlighting the enduring divisiveness of abortion policy in the United States.

    It comes amid ongoing legal and political battles over reproductive rights and federal drug approval authority.

    Mifepristone, first approved in 2000, is used in combination with misoprostol for medication abortions, a method accounting for the majority of abortions nationwide.

    The FDA’s action not only stokes political tensions but also underscores the complexities of drug regulation where ideological and medical considerations intersect.

    What People Are Saying

    Pence, who has repeatedly criticized Trump in the aftermath of the January 6 riots, said in a post on X: “The Trump Administration’s approval of a generic chemical abortion drug is a complete betrayal of the pro-life movement that elected President Trump.

    “Earlier this year, I opposed RFK’s nomination because he was unfit for the role and particularly over the concern that he would expand access to abortion, as he has done today.

    “President Trump must immediately reverse this decision. RFK must resign and give President Trump the opportunity to appoint a new Secretary of HHS who will protect the sanctity of life. The fight for life continues.”

    Missouri Republican U.S. Senator Josh Hawley said on X: “This is shocking. FDA has just approved ANOTHER chemical abortion drug, when the evidence shows chemical abortion drugs are dangerous and even deadly for the mother. And of course 100% lethal to the child.

    “FDA had promised to do a top-to-bottom safety review of the chemical abortion drug, but instead they’ve just greenlighted new versions of it for distribution. I have lost confidence in the leadership at FDA.”

    Oklahoma Republican Congressman Josh Brecheen said: “The FDA just approved the generic counterpart for mifepristone, the abortion pill. Abortion is one of the defining evils of our time, and we must acknowledge that it is murder in every form. 1 in 10 women who take the abortion pill face serious complications, at a rate 22x higher than initially reported by the FDA. How can this be considered safe for unborn children or women?”

    Prominent anti-abortion activist Lila Rose said: “UNACCEPTABLE: The FDA just approved another generic of the abortion pill mifepristone. This drug starves babies and harms mothers! The FDA just said it would do a new serious safety study—so why approve a another generic now?  Robert Kennedy Jr. must reverse this decision!”

    Reproductive Freedom for All account posted on X: “The FDA approved a new generic version of mifepristone, a pill that has been safely and effectively used in abortion and miscarriage care for over two decades. Thank you to the civil servants who made this happen.”

    What To Know

    In a letter to Republican attorneys general last month, Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Dr. Marty Makary pledged to conduct a full review of mifepristone, which was approved 25 years ago and has repeatedly been deemed safe and effective by FDA scientists.

    Generic approvals are usually considered routine. After the patent on the original drug expires, multiple drugmakers often enter the market with cheaper versions. To receive approval, companies must demonstrate that their product is chemically identical to the original. In most cases, such reviews are completed within 10 months.

    But Evita’s application took far longer. According to FDA filings, the company submitted its request four years ago. The FDA did not explain the delay.

    What Happens Next

    Approval of Evita’s pill is not expected to significantly alter access to mifepristone. The medication is typically prescribed with misoprostol, a second drug that causes the uterus to contract and empty. Together, the two drugs account for roughly two-thirds of U.S. abortions. Mifepristone blocks the hormone progesterone and softens the cervix to prepare the body for expulsion.

    [ad_2]

    Source link

  • Government Shutdown Looms: Congress Faces Midnight Deadline

    [ad_1]

    Courtesy kosoff via Adobe Stock
    Credit: Courtesy kosoff via Adobe Stock

    Congress is hoping to get the sign-off from President Trump by tonight or risk a government shutdown, drastically affecting institution operations across the country.

    If a bipartisan compromise can’t be reached tonight, many government offices will temporarily close, furloughing employees and ceasing function. The United States government is expected to run out of money at midnight Eastern Standard Time tonight, unless congressional leaders can reach a funding agreement that pleases all congressional lawmakers.

    Both parties met with the President at the White House yesterday as a last-ditch effort before tonight’s deadline, but no resolution was reached.

    “If it has to shut down, it’ll have to shut down,” Trump said Friday, according to ABC News. “But they’re [Democrats] the ones that are shutting down government.”

    Congressional Democrats have, once again, blocked the Republicans’ plan for more federal funding over a dispute on healthcare. Republicans reportedly want to push off addressing Medicaid, tax credits and such until later this year, which Democrat lawmakers keep rejecting.

    Democratic votes have been continuously withheld from the Republicans’ push to keep the government open, with plans for an orderly shutdown underway, per The New York Times.

    “I think we’re headed to a shutdown because the Democrats won’t do the right thing,” Vice President JD Vance said after the meeting Monday afternoon, according to ABC News.

    The shutdown could directly impact as many as 4 million federal employees, who may be living without pay. Additionally, roughly 2 million military troops could be forced to work without pay, including the hundreds of National Guard employees currently deployed in major U.S. cities, including Los Angeles.

    Agencies like TSA, the FDA, the Labor Department, Medicare and Social Security may all be affected by nationwide slowdowns, meaning — of many calamitous aftereffects — food safety cannot be necessarily confirmed and certain life-saving payments could face distribution issues.

    This would be the first government shutdown since 2019, during Trump’s first term, which was the longest federal shutdown in history at 35 days.

    [ad_2]

    Daisy Levine

    Source link

  • After massive shrimp recalls, the FDA finds radioactive contamination in spices too

    [ad_1]

    Federal regulators have detected possible radioactive contamination in a second food product sent to the U.S. from Indonesia, even as recalls of potentially tainted shrimp continue to grow. The discovery adds to questions about the source of the unusual problem.Related video above: FDA investigates radioactive contamination in Walmart shrimpU.S. Food and Drug Administration officials last week blocked import of all spices from PT Natural Java Spice of Indonesia after federal inspectors detected cesium 137 in a shipment of cloves sent to California.That follows the import alert imposed in August on the company PT Bahari Makmuri Sejati, or BMS foods, which sends millions of pounds of shrimp to the U.S. each year.Here’s what you need to know about potential cesium 137 contamination:What is cesium 137?Cesium 137 is a radioactive isotope created as a byproduct of nuclear reactions, including nuclear bombs, testing, reactor operations and accidents. It’s widespread around the world, with trace amounts found in the environment, including soil, food and air.What have U.S. officials found?U.S. Customs and Border Protection officials detected cesium 137 in shipping containers of shrimp sent by PT Bahari Makmur Sejati to several U.S. ports. CBP officials flagged the potential contamination to the FDA, which tested samples of the shrimp and detected cesium 137 in one sample of breaded shrimp.The company has sent about 84 million pounds (38 million kilograms) of shrimp to U.S. ports this year, according to data from Import Genius, a trade data analysis company. It supplies about 6% of foreign shrimp imported in the U.S.This month, FDA officials detected cesium 137 in one sample of cloves exported by PT Natural Java Spice, which sends spices to the U.S. and other countries. Records show the company sent about 440,000 pounds ( 200,000 kilograms) of cloves to the U.S. this year.What are the health risks?No food that triggered alerts or tested positive has been released for sale in the U.S., FDA officials emphasized.But hundreds of thousands of packages of imported frozen shrimp sold at Kroger and other grocery stores across the U.S. have been recalled because they may have been manufactured under conditions that allowed them to be contaminated, the agency said.Although the risk appears to be small, the foods could pose a “potential health concern” for people exposed to low levels of cesium 137 over time.The levels of contamination detected are far below the level that could trigger the need for health protections, but long-term exposure could raise the risk of certain cancers.Where did the contamination come from?It’s not clear whether there’s a common source of contamination for the shrimp and the spices. FDA and CBP officials said their investigations are continuing. The two processing facilities appear to be about 500 miles (800 kilometers) apart in Indonesia.Contaminated scrap metal or melted metal at an industrial site near the shrimp processing plant in Indonesia may be the source of the radioactive material, according to the International Atomic Energy Agency. Nuclear regulators in Indonesia said they detected the radioactive isotope at the site outside Jakarta.It’s possible that that type of contamination could come from recycling old medical equipment that contained cesium 137, according to Steve Biegalski, a nuclear medicine expert at the Georgia Institute of Technology.Contaminated transport containers or shipping methods, such as trucks, boats or shared materials could also be a source, he said.What should consumers do?For now, consumers should avoid eating or serving shrimp recalled for possible cesium 137 contamination, the FDA said.To date, four firms have issued recalls of shrimp since August, including those listed here.1. Aug. 21, 2025: Southwind Foods, LLC Recall2. Aug. 22, 2025: Beaver Street Fisheries, LLC Recall3. Aug. 27, 2025: AquaStar (USA) Corp Recall – Kroger Brand4. Aug. 28, 2025: AquaStar (USA) Corp Recall – Aqua Star Brand5. Aug. 29, 2025: Southwind Foods, LLC Recall – Expansion of original recall6. Sept. 19, 2025: AquaStar (USA) Corp Recall – Expansion of original recall7. Sept. 23, 2025: Southwind Foods, LLC Recall – Expansion of original recall8. Sept. 23, 2025: Lawrence Wholesale, LLC Recall – Kroger Brand

    Federal regulators have detected possible radioactive contamination in a second food product sent to the U.S. from Indonesia, even as recalls of potentially tainted shrimp continue to grow. The discovery adds to questions about the source of the unusual problem.

    Related video above: FDA investigates radioactive contamination in Walmart shrimp

    U.S. Food and Drug Administration officials last week blocked import of all spices from PT Natural Java Spice of Indonesia after federal inspectors detected cesium 137 in a shipment of cloves sent to California.

    That follows the import alert imposed in August on the company PT Bahari Makmuri Sejati, or BMS foods, which sends millions of pounds of shrimp to the U.S. each year.

    Here’s what you need to know about potential cesium 137 contamination:

    What is cesium 137?

    Cesium 137 is a radioactive isotope created as a byproduct of nuclear reactions, including nuclear bombs, testing, reactor operations and accidents. It’s widespread around the world, with trace amounts found in the environment, including soil, food and air.

    What have U.S. officials found?

    U.S. Customs and Border Protection officials detected cesium 137 in shipping containers of shrimp sent by PT Bahari Makmur Sejati to several U.S. ports. CBP officials flagged the potential contamination to the FDA, which tested samples of the shrimp and detected cesium 137 in one sample of breaded shrimp.

    The company has sent about 84 million pounds (38 million kilograms) of shrimp to U.S. ports this year, according to data from Import Genius, a trade data analysis company. It supplies about 6% of foreign shrimp imported in the U.S.

    This month, FDA officials detected cesium 137 in one sample of cloves exported by PT Natural Java Spice, which sends spices to the U.S. and other countries. Records show the company sent about 440,000 pounds ( 200,000 kilograms) of cloves to the U.S. this year.

    What are the health risks?

    No food that triggered alerts or tested positive has been released for sale in the U.S., FDA officials emphasized.

    But hundreds of thousands of packages of imported frozen shrimp sold at Kroger and other grocery stores across the U.S. have been recalled because they may have been manufactured under conditions that allowed them to be contaminated, the agency said.

    Although the risk appears to be small, the foods could pose a “potential health concern” for people exposed to low levels of cesium 137 over time.

    The levels of contamination detected are far below the level that could trigger the need for health protections, but long-term exposure could raise the risk of certain cancers.

    Where did the contamination come from?

    It’s not clear whether there’s a common source of contamination for the shrimp and the spices. FDA and CBP officials said their investigations are continuing. The two processing facilities appear to be about 500 miles (800 kilometers) apart in Indonesia.

    Contaminated scrap metal or melted metal at an industrial site near the shrimp processing plant in Indonesia may be the source of the radioactive material, according to the International Atomic Energy Agency. Nuclear regulators in Indonesia said they detected the radioactive isotope at the site outside Jakarta.

    It’s possible that that type of contamination could come from recycling old medical equipment that contained cesium 137, according to Steve Biegalski, a nuclear medicine expert at the Georgia Institute of Technology.

    Contaminated transport containers or shipping methods, such as trucks, boats or shared materials could also be a source, he said.

    What should consumers do?

    For now, consumers should avoid eating or serving shrimp recalled for possible cesium 137 contamination, the FDA said.

    To date, four firms have issued recalls of shrimp since August, including those listed here.

    [ad_2]

    Source link

  • You’ll Never Guess Which Food Just Got Recalled Again for Being Radioactive

    [ad_1]

    U.S. food safety officials have issued multiple warnings over the past five weeks about shrimp on supermarket shelves that could be radioactive. But this week has seen even more recalls than usual, with four new warnings for various brands of shrimp since Sunday.

    The latest recalls are for shrimp from Lawrence Wholesale, Southwind Foods, and AquaStar, distributed across the country in enough forms to make Bubba from Forrest Gump proud: frozen raw shrimp, shrimp skewers, cooked shrimp, and cocktail shrimp.

    The shrimp recalls started last month after Great Value frozen raw shrimp sold at Walmart was flagged for potentially being contaminated with Cesium-137. The Cs-137 found in that shrimp measured 68 Bq/kg, below the standard for federal intervention, which sits at 1200 Bq/kg. But officials were still concerned because prolonged exposure to small amounts of radiation can lead to health problems.

    The cause of the potential contamination in all these shrimp is still unclear, though the FDA warns the shrimp was potentially packaged and prepared in “unsanitary conditions.” No product that’s reached supermarket shelves has yet tested positive for Cs-137, according to the FDA. You’ll notice all the FDA warnings say “may have become contaminated.”

    But that didn’t stop Sen. John Kennedy, a Republican from Louisiana, who recently took to the floor of the Senate to warn that eating all this shrimp will turn you into an “alien from the movie Alien.” Seriously.

    Here’s the full list of shrimp to look out for:

    AquarStar shrimp at over a dozen retailers

    On Sunday, Sept. 21, the FDA issued a recall for three different kinds of AquaStar shrimp:

    • 49,920 bags (2-pound) of Kroger Raw Colossal EZ Peel Shrimp
    • 18,000 bags (2-pound) of Kroger Mercado Cooked Medium Peeled Tail-Off Shrimp
    • 17,264 bags (2-pound) of AquaStar Raw Peeled Tail-on Shrimp Skewers

    The shrimp was sold in 32 states between June 12, 2025 and September 17, 2025 at:

    • Baker’s
    • City Market
    • Dillons
    • Food 4 Less
    • Foodsco
    • Fred Meyer
    • Fry’s
    • Gerbes
    • Jay C
    • King Soopers
    • Kroger
    • Mariano’s
    • Metro Market
    • Pay Less Supermarkets
    • Pick ‘n Save
    • Ralphs
    • Smith’s
    • QFC

    AquaStar shrimp at Food Lion

    On Tuesday, the FDA also issued a new recall for 8,000 bags of AquaStar Raw Peeled Tail-on Shrimp Skewers sold in Food Lion stores between July 7, 2025, and Sept. 20, 2025.

    The states where that shrimp was sold:

    • Delaware
    • Georgia
    • Kentucky
    • Maryland
    • North Carolina
    • Pennsylvania
    • South Carolina
    • Tennessee
    • Virginia
    • West Virginia

    Lawrence Wholesale shrimp at Kroger

    Another recall issued Tuesday by the FDA involves Lawrence Wholesale shrimp sold at Kroger. The bagged frozen shrimp and cocktail shrimp includes best-by dates in April and May of 2027, with the full lot codes available on the federal agency’s website.

    • Alabama
    • Alaska
    • Arizona
    • Arkansas
    • California
    • Colorado
    • Georgia
    • Idaho
    • Illinois
    • Indiana
    • Kansas
    • Kentucky
    • Louisiana
    • Michigan
    • Mississippi
    • Missouri
    • Montana
    • Nebraska
    • Nevada
    • New Mexico
    • Ohio
    • Oregon
    • South Carolina
    • Tennessee
    • Texas
    • Utah
    • Virginia
    • Washington
    • West Virginia
    • Wisconsin
    • Wyoming

    Southwind Foods

    Still another recall was issued Tuesday for a wide variety of shrimp brands distributed by Southwind Foods between June 24 and September 16, 2025.

    The full list can be found in a PDF from the FDA’s website with full lot listings and product weight specifics, but the brands include:

    • Arctic Shores
    • Best Yet
    • First Street
    • Great American
    • Kroger
    • Master Catch
    • Phosphate Free IQF Tovala
    • Sand Bar
    • Winco

    Paris Martineau, a journalist at Consumer Reports, commented on how rapid the recalls were coming this week.

    tuesday marked the 5th time in 5 weeks that shrimp was recalled for possible radioactive contamination

    yesterday, two NEW recalls were issued. then, literally as i was reporting those out, *another* company announced a radiation-related shrimp recall www.consumerreports.org/health/food-…

    [image or embed]

    — paris martineau (@paris.nyc) September 26, 2025 at 7:05 AM

    Again, the FDA isn’t claiming that any of this shrimp is definitely radioactive. And the American Nuclear Society notes that the 68 Bq/kg reading found last month is similar to the radiation levels found in bananas. It’s just not the kind of thing you want repeated exposure to, especially since the radiation in bananas (potassium-40) is natural, and Cesium-137 only exists because we decided to usher humanity into the nuclear age in 1945.

    But it’s probably better to be safe than sorry.

    [ad_2]

    Matt Novak

    Source link

  • Florida likely ‘in line’ with unproven Tylenol-autism link – Orlando Weekly

    [ad_1]

    Credit: via Joseph A. Ladapo/X

    State Surgeon General Joseph Ladapo said Florida isn’t ready to make recommendations on the use of acetaminophen by pregnant women.

    But if one comes, Ladapo said it likely will follow Monday’s announcement from the White House that suggested a link between the common painkiller and autism.

    “We’re still looking at it,” Ladapo said Wednesday during an appearance in Tampa. “So we may have some more guidance. But we would probably be very much in line with where the FDA (U.S. Food and Drug Administration) is.”

    President Donald Trump, joined by U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. and federal Centers for Medicare and Medicaid Services head Mehmet Oz, said Monday the Food and Drug Administration would update drug labeling to discourage the use of acetaminophen, commonly known as Tylenol, by pregnant women. At the same time, the FDA is set to enable the use of leucovorin, a form of vitamin B, as a treatment for autism.

    Ladapo said the White House and the FDA are “at a place that is more honest.”

    “They acknowledge that not all the studies show harms, but some of them do show relationships,” Ladapo said. “And it isn’t a total explanation for autism by any means, but it does appear to be that it’s reasonable to conclude that it may contribute anything to the prevalence of autism in children. So, you know, not all the studies find that, but some of the studies do. Some of those studies are very good. So I think that their recommendation is the right place to be in terms of discouraging its use.”

    But in a statement responding to the White House announcement, Steven J. Fleischman, president of the American College of Obstetricians and Gynecologists, said it was “highly unsettling that our federal health agencies are willing to make an announcement that will affect the health and well-being of millions of people without the backing of reliable data.”

    Tylenol-maker Kenvue disputed the claims.

    “We believe independent, sound science clearly shows that taking acetaminophen does not cause autism,” Kenvue said in a statement.


    Subscribe to Orlando Weekly newsletters.

    Follow us: Apple News | Google News | NewsBreak | Reddit | Instagram | Facebook Bluesky | Or sign up for our RSS Feed


    ‘For decades, the Attorney General’s Office has functioned to prop up the powerful and corrupt’

    ‘Alligator Alcatraz’ and ‘Deportation Depot’ are Florida’s two main detention centers working in conjunction with ICE

    ‘So, you know, not all the studies find that, but some of the studies do,’ Florida Surgeon General Ladapo said



    [ad_2]

    Jim Turner, News Service of Florida
    Source link
  • 3,000 Pounds of Poke From Costco Recalled for a Surprising Reason

    [ad_1]

    Have you recently purchased Kirkland Signature brand Ahi Tuna Wasabi Poke from Costco? You should check to make sure it wasn’t part of a new recall.

    Western United Fish Company (also known as Annasea Foods Group) of Kent, Washington, has issued a recall for 3,314 pounds of Kirkland Signature brand Ahi Tuna Wasabi Poke packed on Sept. 18, 2025, with a sell-by date of Sept. 22, 2025.

    The recall is over concerns about Listeria contamination, which can be fatal among young kids, the elderly, and people with weakened immune systems. Otherwise healthy people can still have serious symptoms from listeria infection, including high fever, bad headaches, stiffness, nausea, abdominal pain, and diarrhea, according to the FDA.

    The poke was packaged in plastic clamshell containers with Kirkland Signature branding, though it was produced by Western United Fish Company/Annasea Foods Group. Consumers are being told to dispose of the product immediately and request a full refund from their local Costco.

    The concern over listeria is actually focused on the green onions that were included in the product rather than the raw fish.

    “This recall was initiated after being notified by our green onion supplier of a Listeria monocytogenes positive test result in the green onions which were used only in Ahi Tuna Wasabi Poke on 9/17/2025,” the company said in a statement posted to the FDA website. “We are continuing to work with our green onion supplier to determine the root cause.”

    The states where the poke has been recalled:

    • Alabama
    • Alaska
    • Colorado
    • Connecticut
    • Delaware
    • Florida
    • Georgia
    • Idaho
    • Indiana
    • Louisiana
    • Maine
    • Maryland
    • Massachusetts
    • Minnesota
    • Mississippi
    • Missouri
    • Montana
    • Nebraska
    • New Hampshire
    • New Jersey
    • New Mexico
    • New York
    • North Carolina
    • Ohio
    • Oregon
    • Pennsylvania
    • South Carolina
    • Tennessee
    • Texas
    • Utah
    • Virginia
    • Washington
    • Wisconsin

    Listeria can be a very serious problem. Back in June, chicken fettuccine alfredo meals sold at Kroger and Walmart were recalled after 17 people became ill and 3 people actually died, according to NPR. It turned out they were contaminated with listeria. One woman also lost a fetus, which is why pregnant people are advised to be particularly alert when recalls over listeria happen.

    Experts have expressed concern over the Trump regime’s cuts to America’s food safety monitoring programs in recent months. The CDC quietly cut back the Foodborne Diseases Active Surveillance Network (or FoodNet), which tracks foodborne illness, according to a startling report from the New York Times. And one of the concerns is that most people won’t really notice the change until it’s too late. In a country of over 330 million people, a handful of people dying from a given outbreak is barely noticed. But if food safety regulators don’t have the data to spot an outbreak, those handful of deaths can grow unnecessarily.

    Consumers with any questions about the Costco poke recall are being encouraged to contact Western United Fresh Co./Annasea Foods Group by calling 425-558-7809 between the hours of 10 a.m. and 6:30 p.m. ET (7 a.m. to 3:30pm PT) Monday to Friday, or to email: [email protected].

    [ad_2]

    Matt Novak

    Source link

  • CDC vaccine advisory panel changes guidance for COVID-19 shots

    [ad_1]

    DENVER — The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices declined to recommend the COVID-19 vaccine to anyone, even those at high risk, leaving people to choose for themselves whether to get it.

    Until now, COVID-19 vaccinations had been recommended as a routine shot each fall, like a flu vaccine.

    The advisors also urged the CDC to adopt stronger language around claims of vaccine risks, despite pushback from outside medical groups that say the shots have a proven safety record from billions of doses administered worldwide.

    The Associated Press reports that among many unproven questions about risks that the panel raised Friday was one rare side effect that people already are warned about: a kind of heart inflammation called myocarditis, mostly in young men, that was discovered in the early days of vaccination in 2021. A scientist studying whether people with certain genes are uniquely susceptible to that risk told the panel the Trump administration had canceled his grant before the research could be finished.

    The divided panel narrowly avoided urging states to require a prescription for the COVID-19 shot.

    What is the CDC’s vaccine advisory panel and why is it so influential?

    On Thursday, the panel voted to change its age recommendations for the measles, mumps, rubella and varicella (MMRV) vaccine.

    In an 8-3 vote, the panel decided to change the recommended minimum age for receiving the MMRV vaccine, which combines the MMR vaccine and the chickenpox vaccine, to 4 years old, and that children in this age group instead get separate vaccines — one against MMR and another for varicella, or chickenpox.

    Since 2009, the CDC has said it prefers separate shots for initial doses of those vaccines, and 85% of toddlers already do.

    In a move that surprised some medical groups, the panel delayed recommending whether to end the longstanding CDC recommendation that all newborns be vaccinated at birth against the liver virus, hepatitis B.

    The Associated Press reports that the panel had been considering whether to recommend delaying that initial vaccination — something doctors and parents already can choose to do. However, amid criticism from independent pediatric and infectious disease specialists who say the vaccine is safe and has helped infant infections drop sharply, the advisers decided Friday to postpone that decision.

    Scripps News Group and the Associated Press contributed to this report.

    Denver7

    Denver7 | Your Voice: Get in touch with Shannon Ogden

    Denver7 evening anchor Shannon Ogden reports on issues impacting all of Colorado’s communities, but specializes in covering local government and politics. If you’d like to get in touch with Shannon, fill out the form below to send him an email.

    [ad_2]

    Shannon Ogden

    Source link

  • This protein powder is made out of air and uses 600 times less water than beef

    [ad_1]

    Thanks to innovations in food science and agriculture, the world is producing more food than ever before. While this has significantly reduced global hunger since the 1970s, it has impacted the environment; in 2023, food production generated about 26 percent of global greenhouse gas emissions, according to Our World in Data.

    Now scientists at the Finnish startup Solar Foods are turning air and electricity into food. The result? A mustard-colored protein powder made from naturally occurring microbes that could reshape how the world is fed.

    Inside a bioreactor, a single microbe plucked from the Finnish dirt is fed a cocktail
of carbon dioxide, nitrogen, calcium, phosphorus, and potassium. Renewable electricity powers the process, which the company says is “20 times more efficient than photosynthesis,” and accelerates the growth of the microorganism into a protein-rich slurry.

    After drying, what’s left is Solein: a fine powder packed with all nine essential amino acids, unsaturated fats, dietary fiber, and vitamin B12. According to Food & Wine, 100 grams of the powder yields 75 grams of protein, which is comparable to many whey protein powders on the market.

    Solein, which the company describes as having a “pleasant note of umami flavor,” requires 600 times less water and 200 times less land to produce one kilogram of protein than is required to produce one kilogram of beef. The protein is also more efficient than other available vegan and plant proteins.

    As of July 2024, the company had raised $47 million in equity funding and has been listed on the Nasdaq’s First North Growth Market in Finland. It recently received a $10.6 million grant from the European Commission.

    In May, Solar Foods’ pilot facility ramped up its production 100-fold, reaching industrial scale and proving its ability to commercialize. It is currently in the pre-engineering phase of a second industrial production facility, with a third and fourth one possibly on the way.

    The Food and Drug Administration has given the company a “Generally Recognized as Safe” designation, allowing Solein to be commercialized in the United States. In March, Solar Foods announced its first multimillion-dollar supply agreement with Superb Food, “a startup with a mission to advance community health through smart functional foods.” In 2024, the company was selected as one of the winners of NASA’s Deep Space Food Challenge, which was launched to develop food innovations for space travel.

    [ad_2]

    Jeff Luse

    Source link

  • Apple Watch Series 11 receives FDA approval for hypertension alerts

    [ad_1]

    Apple’s Awe Dropping event started with dramatic health testimonials from Apple Watch users, then revealed a key new feature for the new Watch Series 11: hypertension alerts. The function had yet to receive FDA approval at the time, but that has now been granted, according to Bloomberg. As a result, it will reportedly be available to users in 150 countries when the Watch 11 and Ultra Watch 3 ship starting on September 19.

    Hypertension alerts can help detect hypertension (high blood pressure), a potentially dangerous condition that affects over a billion people. The feature relies on the Watch’s optical heart sensor, but now uses new machine learning algorithm that also draws from a study involving more than 100,000 participants to look for high blood pressure. It works in the background a month-long period to seek patterns associated with hypertension. Unlike devices that measure your specific blood pressure, it only tells users that there may be a danger.

    Last year, Apple received the FDA’s nod for its over-the-counter Hearing Aid function that transforms the second-gen AirPods Pro into OTC hearing aids for people with mild-to-moderate hearing loss. Another recently approved feature is sleep apnea detection. However, the company is currently facing a lawsuit over the Apple Watch’s redesigned blood oxygen monitoring feature.

    [ad_2]

    Steve Dent

    Source link